GGrantIndex
Sort

17,828 grants matching crispr

High-throughput systematic characterization of regulatory element function

$1,032,594
William James Greenleaf · Stanford University · UM1 · FY2020 · HG

Spatial functional genomics to identify regulators of the tumor microenvironment and cancer immunity

$1,032,278
Brian D Brown · Icahn School Of Medicine At Mount Sinai · U01 · FY2023 · CA

Gene Targeting Core, NIDCR DIR

$1,030,312
Roman Szabo · National Institute Of Dental & Craniofacial Research · ZIC · FY2025 · DE

Epigenetic regulation of cellular plasticity and cancer cell fate

$1,030,140
Yang Shi · Boston Children'S Hospital · R35 · FY2019 · CA

The Cancer Target Discovery and Development Network at UCSF

$1,029,182
Michael T McManus · University Of California, San Francisco · U01 · FY2020 · CA

Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease

$1,027,273
Aaron D. Gitler · Stanford University · R35 · FY2019 · NS

Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease

$1,027,273
Aaron D. Gitler · Stanford University · R35 · FY2018 · NS

Innovating Yeast and Human Genetics Approaches to Define Mechanisms of Neurodegenerative Disease

$1,027,273
Aaron D. Gitler · Stanford University · R35 · FY2022 · NS

The Cancer Target Discovery and Development Network at UCSF

$1,026,728
Michael T McManus · University Of California, San Francisco · U01 · FY2021 · CA

Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids

$1,026,181
Calvin J Kuo · Stanford University · U01 · FY2017 · CA

Understanding the pathogenesis of and identifying treatments for albinism

$1,026,020
Brian Brooks · National Eye Institute · ZIA · FY2025 · EY

Immunological Analysis of Brain Cancer

$1,025,686
Masaki Terabe · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Mechanisms and Vulnerabilities of Aberrant Transcriptional Enhancers in Cancer

$1,025,513
A Thomas Look · Dana-Farber Cancer Inst · R35 · FY2022 · CA

A multi-faceted approach to identifying K-Ras synthetic lethal relationships

$1,025,393
Kevin Michael Haigis · Beth Israel Deaconess Medical Center · U01 · FY2016 · CA

Conditional genetics and precision genome editing resources for Zebrafish

$1,023,185
Maura A. McGrail · Iowa State University · R24 · FY2024 · OD

RNAi Screening in Hematopoietic Cells

$1,022,358
Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI

Functional decoding of signaling dynamics in single immune cells

$1,019,822
Myong-Hee Sung · National Institute On Aging · ZIA · FY2019 · AG

RNAi Screening in Hematopoietic Cells

$1,019,714
Iain Fraser · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Identifying Metabolic Dependencies of Pancreatic Cancers

$1,017,000
Alec Kimmelman · New York University School Of Medicine · R35 · FY2021 · CA

Differential function and tumor vulnerabilities revealed by RAS membrane trafficking

$1,017,000
Mark Reid Philips · New York University School Of Medicine · R35 · FY2021 · CA

Differential function and tumor vulnerabilities revealed by RAS membrane trafficking

$1,016,977
Mark Reid Philips · New York University School Of Medicine · R35 · FY2025 · CA

Therapeutic Disruption of HIV Transcription by HIV-1 Tat Protein-Degrading Molecules

$1,016,887
Susana T Valente · University Of Florida · R01 · FY2025 · AI

Modeling KRAS-Dependent Synthetic Lethality in Human Colon Organoids

$1,016,593
Calvin J Kuo · Stanford University · U01 · FY2016 · CA

Integrating systems immunology with immunometabolism and cancer immunity

$1,016,190
Hongbo Chi · St. Jude Children'S Research Hospital · R35 · FY2024 · CA

CRISPR-BASED GENE EDITING TO INDUCE THERMOGENIC ADIPOSE TISSUE IN TYPE 2 DIABETES

$1,015,617
University Of Massachusetts Medical School · · FY2018 · Department of the Army